Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
134,608,103
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
98,377,909
-
Shares change
-
+4,773,734
-
Total reported value, excl. options
-
$781,109,580
-
Value change
-
+$30,778,538
-
Put/Call ratio
-
80%
-
Number of buys
-
57
-
Number of sells
-
53
-
Price
-
$7.94
Institutional Holders of Tango Therapeutics, Inc. - Common Stock (TNGX) as of Q1 2024
As of 31 Mar 2024 Tango Therapeutics, Inc. - Common Stock (TNGX) had 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 98,377,909 shares of stock of the company.
Largest 10 holders included TRV GP IV, LLC, EcoR1 Capital, LLC, FMR LLC, Boxer Capital, LLC, Nextech Invest Ltd., Southpoint Capital Advisors LP, T. Rowe Price Investment Management, Inc., BlackRock Inc., VANGUARD GROUP INC, and Bain Capital Life Sciences Investors, LLC.
This table shows 124 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.